A mastic gum extract induces supression of growth of human colorectal tumor xenografts in immunodeficient mice

In Vivo

Volumn 23, Issue 1, 2009, Pages 63-68

  Dimas, Konstantinos ^a   Hatziantoniou, Sophia ^b   Wyche, James H ^c   Pantazis, Panayotis ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Colon cancer; Mastic gum; Tumor suppression

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; HEXANE; MASTIC GUM EXTRACT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL STRAIN HCT116; COLORECTAL TUMOR; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PISTACIA LENTISCUS; PLANT PRODUCT; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HCT116 CELLS; HUMANS; MALE; MICE; MICE, SCID; PISTACIA; PLANT EXTRACTS; RESINS, PLANT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 63049088217     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal caner. Cell 87: 159-170, 1996.
2. Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC, Tecle H, Barrett SD, Bridges A, Przybranowski S, Leopold WR and Saltiel AR: Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 5: 736-737, 1999.
3. Gupta RA and Dubois RN: Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1: 11-21, 2001.
4. Samowitz WS and Slattery ML: Missense mismatch repair gene alterations, microsatellite instability, and hereditary nonpolyposis colorectal gene. J Clin Oncol 20: 1203-1208, 2002.
5. Liu Z, Ishikawa W, Huang X, Tomotake H, Kayashita J, Watanabe H and Kato N: A buckwheat protein product suppresses 1-2-dimethylhydrazine-induced colon carcinogenesis in rats by reducing cell proliferation. J Nutr 131: 1850-1853, 2001.
6. Wolter F, Glausnitzaer A, Akoglu B. and Stein J: Piceatannol, a natural analog of resveratrol, inhibits progression through the S-phase of the cell cycle in colorectal cell lines. J Nutr 132: 298-302, 2002.
7. Brivida K, Pan L and Rechkemmer G: Red wine polyphenols inhibit the growth of colon carcinoma cells and modulate the activation pattern of mitogen-activated protein kinases. J Nutr 132: 2814-2818, 2002.
8. 1-restriction points in breast and colon cancer cells. J Nutr 133: 3670-3677, 2003.
9. Chauhan D: Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des 8: 1695-1706, 2002.
10. Mueller-Klieser W, Schreiber-Klais S, Walenta S and Kreuter MH: Bioactivity of well-defined green tea extracts in multicellular tumor spheroids. Intl J Oncol 21: 1307-1315, 2002.
11. Kaur M, Singh RP, Gu M, Agarwal R and Agarwal C: Grape seed extract inhibits in vitro and in vivo growth of human colorectal carcinoma cells. Clin Cancer Res 12: 6194-6202, 2006.
12. Smith TK, Mithen R and Johnson IT: Effects of Brassica vegetable juice on the induction of apoptosis and aberrant crypt foci in rat colonic mucosal crypts in vivo. Carcinogenesis 24: 491-495, 2003.
13. Al-Said MS, Ageel AM, Parmar NS and Tariq M: Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity. J Ethnopharmacol 15: 271-278, 1986.
14. Iauk L, Ragusa S, Rapisadra A, Franco S and Nicolosi VM: In vitro antimicrobial activity of Pistacia lentiscus L. extracts: Preliminary report. J Chemother 8: 207-209, 1996.
15. Koutsoudaki C, Krsek M and Rodger A: Chemical composition and antimicrobial activity of the essential oil and the gum of Pistacia lentiscus var. chia. J Agric Food Chem 53: 7681-7685, 2005.
16. Sterer N: Antimicrobial effect of mastic gum methanolic extract against Porphyromonas gingivalis. J Med Food 9: 290-292, 2006.
17. Paraschos S, Magiatis P, Mitakou S, Petraki K, Kalliaropoulos A, Maragkoudakis P, Mentis A, Sgouras D and Skaltsounis AL: In vitro and in vivo activity of Chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob Agents Chemother 57: 551-559, 2007.
18. Marner FG, Freyer A and Lex J: Triterpenoids from gum mastic, the resin of Pistacia lentiscus. Phytochemistry 30: 3709-3712, 1991.
19. Papageorgiou VP, Mellidis AS and Argyriadou N: The chemical composition of the essential oil of mastic gum. J Ess Oil Res 3: 107-111, 1991.
20. Balan KV, Demetzos C, Prince J, Dimas K, Cladaras M, Han Z, Wyche JH and Pantazis P: Induction of apoptosis in human colon cancer HCT116 cells treated with an extract of the plant product, Chios mastic gum. In Vivo 19: 93-102, 2005.
21. Strasser A, O'Connor L and Dixit VM: Apoptosis signalling. Annu Rev Biochem 69: 217-245, 2001.
22. Degrerev A, Boyce M and Yuab J: A decade of caspases. Oncogene 22: 8543-8567, 2003.
23. Salvage GS and Abrams JM. Caspase activation - stepping on the gas or releasing the brakes? Lessons from humans and flies, Oncogene 23: 2774-2784, 2004.
24. Johnson CR and Jarvis WD. Caspase-9 regulation: an update. Apoptosis 9: 423-427, 2004.
25. Balan KV, Prince J, Han Z, Hadjopoulou-Cladaras M, Sitaras NM, Dimas K, Wyche JH and Pantazis P: Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from Pistacia lentiscus L. var. chia. Phytomedicine 14: 263-272, 2007.
26. He M-L, Yuan H-O, Jiang A-L, Gong AY, Chen W-W, Zhang P-J, Young CYF, Zhang J-Y. Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells. Cancer 106: 2547-2555, 2006.
27. Corbett T, Valeriote F, LoRusso P, Polin L, Pancharov C, Pugh S, Whyte K, Knight J, Demchick L, Jones J, Jones L and Lissow L: In vivo methods for screening and preclinical testing. In Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval. Teicher B, Totowa NJ (ed.). Humana Press, pp. 75-99, 1997.
28. Hatziantoniou S, Dimas K, Georgopoulos A, Sotiriadou N and Demetzos C: Cytotoxic and antitumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts. Pharmacol Res 53: 80-87, 2006.
29. Dimas K, Hatziantoniou S, Tseleni S, Khan H, Georgopoulos A, Alevizopoulos K, Wyche JH, Pantazis P and Demetzos C: Sclareol induces apoptosis in human HCT116 colon cancer cells in vitro and suppression of HCT116 tumor growth in immunodeficient mice. Apoptosis 12: 685-694, 2007.
30. Collins AR: Antioxidant intervention as a route to cancer chemoprevention. Eur J Cancer 41: 1923-1930, 2005.
31. D'Incalci M, Steward WP and Gescher A: Use of cancer chemopreventive phytochemicals as antineoplastic agents. Lancet Oncol 6: 899-904, 2005.
32. Shimizu M and Weinstein IB: Modulation of signal transduction by tea catechins and related phytochemicals. Mut Res 591: 147-160, 2005.
33. Garcia GE, Nicole A, Bhaskaran S, Gupta A, Kyprianou N and Kumar AP: Akt- and CREB-mediated prostate cancer cell proliferation inhibition by nextrutine, a Phellodendron amurense extract. Neoplasia 8: 523-533, 2006.